1. Home
  2. CC vs NVCR Comparison

CC vs NVCR Comparison

Compare CC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemours Company (The)

CC

Chemours Company (The)

HOLD

Current Price

$14.77

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.54

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CC
NVCR
Founded
2014
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
CC
NVCR
Price
$14.77
$17.54
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$20.11
$28.08
AVG Volume (30 Days)
2.7M
1.7M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$6,638,000,000.00
$655,353,000.00
Revenue This Year
$6.15
$7.72
Revenue Next Year
$5.95
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
7.36
8.28
52 Week Low
$10.44
$9.82
52 Week High
$28.67
$21.45

Technical Indicators

Market Signals
Indicator
CC
NVCR
Relative Strength Index (RSI) 36.32 56.60
Support Level $14.43 $12.85
Resistance Level $16.58 $18.48
Average True Range (ATR) 0.86 1.21
MACD -0.10 0.08
Stochastic Oscillator 5.06 39.50

Price Performance

Historical Comparison
CC
NVCR

About CC Chemours Company (The)

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: